financetom
Business
financetom
/
Business
/
Williams CEO Alan Armstrong to step down after 14 years at the helm
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Williams CEO Alan Armstrong to step down after 14 years at the helm
May 26, 2025 1:38 AM

May 5 (Reuters) - Williams Companies ( WMB ) said on

Monday CEO Alan Armstrong will step down after more than 14

years at the helm of the U.S. pipeline operator.

Armstrong, who joined Williams nearly 40 years ago, would be

succeeded by insider Chad Zamarin, effective July 1. Zamarin,

who joined the company in 2017, is currently the executive vice

president of corporate strategic development.

Williams on Monday also beat quarterly earnings estimates

and raised its annual profit forecast, as it banked on rising

demand for natural gas, driven by a surge in electricity

consumption by homes, businesses, crypto-mining, and an

artificial intelligence-led boom in data centers.

"Williams is well positioned to benefit from the coming wave

of natural gas demand from the power generation market and LNG

exports, while continuing to deliver on traditional market

needs," Armstrong said.

The firm raised its 2025 adjusted core profit to be between

$7.5 billion and $7.9 billion compared to its prior outlook

range of $7.45 billion to $7.85 billion.

Its first-quarter results were boosted by higher service

revenues from expansion projects and acquisitions.

In January, the U.S. energy regulator reinstated the

certificate for Williams' Transcontinental gas pipeline,

allowing it to go ahead with expansion of the project, after a

U.S. court voided the initial approval in 2023.

Total revenue rose nearly 10% to $3.05 billion during the

quarter ended March 31, while service revenues climbed to $2

billion from $1.91 billion a year ago.

At Transco, average daily transportation volumes rose to

15.9 million dekatherms (MMdth) of natural gas per day in the

first quarter from 14.6 MMdth per day of natural gas a year ago.

The company posted an adjusted profit of 60 cents per share

for the quarter ended March 31, compared with average analysts'

estimate of 56 cents per share, according to data compiled by

LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GoldMining Up 2.6% In US Premarket As Reports Additional High-Grade Drilling Results and Identified Multiple Drill Targets, Sao Jorge Project, Brazil
GoldMining Up 2.6% In US Premarket As Reports Additional High-Grade Drilling Results and Identified Multiple Drill Targets, Sao Jorge Project, Brazil
Nov 11, 2024
07:36 AM EST, 11/11/2024 (MT Newswires) -- GoldMining Inc. ( GLDG ) was at last look up 2.6% in US premarket trade -- it was even higher -- as the company reported Monday additional assay results from the 2024 auger drilling program at its 100% owned Sao Jorge Project in the Tapajos gold district, Para State, Brazil. Among highlights, it...
Cigna says it will not pursue combination with Humana
Cigna says it will not pursue combination with Humana
Nov 11, 2024
Nov 11 (Reuters) - Health insurer Cigna Group ( CI ) said on Monday it is not pursuing a combination with peer Humana . ...
Can-Fite BioPharma Doses First Patient in Namodenoson Phase 2a Trial in Pancreatic Cancer
Can-Fite BioPharma Doses First Patient in Namodenoson Phase 2a Trial in Pancreatic Cancer
Nov 11, 2024
07:33 AM EST, 11/11/2024 (MT Newswires) -- Can-Fite BioPharma ( CANF ) said Monday that the first patient has been dosed in its phase 2a trial of Namodenoson in patients with advanced pancreatic adenocarcinoma. The company said it targets to enroll about 20 evaluable patients in the trial. The study's primary objective is to characterize Namodenoson's safety profile, while the...
TriSalus Life Sciences, Geo-Med Partner to Expand TriNav Infusion System Access in VA Medical Centers
TriSalus Life Sciences, Geo-Med Partner to Expand TriNav Infusion System Access in VA Medical Centers
Nov 11, 2024
07:36 AM EST, 11/11/2024 (MT Newswires) -- TriSalus Life Sciences ( TLSI ) said Monday that it has partnered with Geo-Med, a certified service-disabled veteran-owned small business, to expand the availability of its TriNav Infusion System across US Department of Veterans Affairs medical centers. The company said Geo-Med is a key supplier to the Veterans Affairs and the US Department...
Copyright 2023-2026 - www.financetom.com All Rights Reserved